Global Cell Culture Incubator Market Projected to Reach USD 4,305.1 Million by 2033 at a 5.6% of CAGR

Cell Culture Incubators Market
Cell Culture Incubators Market

The global cell culture incubator market is on a robust growth trajectory, with an estimated valuation of USD 2,315.5 million in 2023. According to recent forecasts, the market is expected to reach USD 4,305.1 million by 2033, expanding at a compound annual growth rate (CAGR) of 6.4% during the forecast period from 2023 to 2033. This follows a historical CAGR of 5.6% from 2018 to 2022.

Cell culture incubators are essential devices in biological and medical research, providing a controlled environment for the growth and maintenance of cultured cells and bacterial cultures. These incubators regulate critical parameters such as temperature, pH, oxygen (O2), humidity, and carbon dioxide (CO2) concentrations to support optimal cell development. Standard models typically maintain a temperature range from ambient +4°C to 50°C, a CO2 range of 0.3% to 19.9%, and humidity levels exceeding 80% relative humidity (RH).

The significant growth in the cell culture incubator market is driven by the increasing demand for advanced research tools in biotechnology, pharmaceuticals, and life sciences. The need for precise control of growth conditions for cell cultures is fueling the adoption of sophisticated incubators, which are crucial for drug development, genetic research, and other scientific applications.

Request Your Detailed – Report Sample

An apparatus known as a cell culture incubator maintains bacteria and cell cultures growing inside of a chamber at precisely controlled temperature, humidity, pH, and CO2 concentration. The necessity and approvals for more vaccines based on cell culture are driving the growth of the cell culture incubator market. The target market is expected to grow as a result of the increased need for monoclonal antibodies and the rise in chronic illness prevalence.

A tissue culture incubator is a specialized scientific instrument used for the carefully controlled growth and preservation of cells. It provides steady settings with controlled temperature, humidity, and gas concentrations to encourage the best circumstances for cell development and proliferation.

Market Competition:

The key players of this market include Thermo Fisher Scientific Inc, Memmert GmbH + Co.KG, Binder GmbH, Panasonic, BioIVT, Sheldon Manufacturing, Inc.

  • Thermo Fisher Scientific Inc. announced in June 2021 that the company’s Thermo Scientific Cytomat 24 automated incubators and storage systems are combined with the latest technology to aid increased throughput and sample protection. The new Cytomat 24 automated incubators and storage systems from Thermo Fisher Scientific, which will be available in May 2021, provide a large capacity, quick access, and a wide temperature range while minimizing contamination difficulties in high-throughput applications. The new instruments use temperature consistency and stability to assure reproducibility for cell culture applications, while also providing speedy delivery of microtiter plates via an enhanced plate shuttle system, according to a press release issued by Thermo Fisher on May 14, 2021. The system also incorporates an LED touch screen that is installed on the door for easy access and viewing.
  • BioIVT released its GMP Grade Human AB Serum tailored for gene therapy manufacturing in January 2022. BioIVT’s GMP-grade human AB serum is manufactured with the same optimized processes and improved regulatory control of source material collection, manufacturing, and processing as its research-use only material. However, it also includes extra viral tests and documentation for hepatitis A (plasma-derived only), hepatitis B core antibody, hepatitis E, and parvovirus B19 (plasma-derived only).

Customization Available: Here

Key Segments Profiled In The Cell Culture Incubator Industry Survey:

By Type:

  • Air-jacketed
  • Water-jacketed
  • Direct Heat

By Sensor Technology:

  • Infra-red
  • Thermal Conductivity

By Application:

  • For Pharmaceutical Applications
  • For Biomedical and Clinical Labs
  • For Government Research
  • For IVF Processes
  • For Other Applications

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Explore In-Depth Market Insights: Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *